With the growing sophistication of outsourcing, Pharmaceutical Companies are moving from tactical, case by case, outsourcing to new, more strategic relationships. An increasing number of Sponsors are looking at strategic relationships which are based on more creative outsourcing approaches. The need and sophistication of these outsourcing models are becoming more transformational and need to be based on a strong partnership.
Partnerships 2012 delivers the highest concentration of strategic sourcing clinical decision makers in the world. Through targeted sessions in our strategic sourcing track and future trends in clinical trials track, outsourcing executives learn from a series of case studies featuring the latest outsourcing partnerships, and engage in provocative discussions on outsourcing business model innovation. Go back to the office with new ideas and tools to overcome the current challenges of the implementation of new outsourcing strategies.
1500+ attendees will gather for an all new experience designed to embrace change and TRANSFORM AN INDUSTRY
With 100% of the top CROs and leading vendors and service providers in attendance, you will create strategic alliances to improve your clinical trial development.
|
YOUR PRESSING CHALLENGES ADDRESSED |
|
we have specific sessions just for you!
- The Big Picture: Does One Size Fit All? A Focus on Outsourcing Trends of Small-Midsize BioPharma Companies
- Apply the Large Pharma Model to Small Pharma: What to expect out of Stratetgic Partnerships with your CROs
- Case Study: Outsourcing Selection and Start Up Process for Small Companies Going Global
- Managing Vendors when You're a Small Shop- Working with Limited Resources
- Case Study: Get More from your Key Supplier Relationships-Tips to Influence Required Change Management within Your Organization
- Drug Safety Outsourcing Considerations for Small-Mid-Size Companies: How to Meet Increasing Demands with Limited Resources
- How to Conduct trials in China when you are not big Pharma
- Unique Needs for Medical Devices: Choosing the Right Vendors for your Medical Device Trials
- Applying Metrics Champion Consortium (MCC) Standardized Performance Metrics and Quality Tools to Medical Device Trials
- Setting and Communicating Realistic Expectations for Your Next Medical Device Trial
- The Future of Medical Device R&D- Shift Your Strategy and Business Model to Create New Dimensions of Performance
- Examine the Regulatory Device Pathway to Improve Current Clinical Trials
- Approved Product Spotlight: Boston Scientific Managed its Clinical Trial Process to Attain Recent FDA Approval of its Wallflex Fully Covered Biliary Stent


